SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 44 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,839 | -29.8% | 26,049 | 0.0% | 0.00% | – |
| Q2 2023 | $29,696 | -24.0% | 26,049 | 0.0% | 0.00% | – |
| Q1 2023 | $39,074 | +0.7% | 26,049 | 0.0% | 0.00% | – |
| Q4 2022 | $38,813 | -3.0% | 26,049 | 0.0% | 0.00% | – |
| Q3 2022 | $40,000 | +14.3% | 26,049 | +67.6% | 0.00% | – |
| Q2 2022 | $35,000 | -90.2% | 15,542 | -89.9% | 0.00% | – |
| Q1 2022 | $356,000 | -61.6% | 154,161 | -3.6% | 0.00% | – |
| Q4 2021 | $928,000 | -45.1% | 159,861 | -0.6% | 0.00% | – |
| Q3 2021 | $1,691,000 | +130.7% | 160,758 | +114.3% | 0.00% | – |
| Q2 2021 | $733,000 | -38.4% | 75,011 | -8.5% | 0.00% | – |
| Q1 2021 | $1,190,000 | – | 81,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,540,920 | $2,311,380 | 0.45% |
| Deuterium Capital Management, LLC | 11,000 | $16,500 | 0.03% |
| Duquesne Family Office | 100,000 | $150 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $169,350 | 0.00% |
| LEO BROKERAGE, LLC | 14,845 | $22,268 | 0.00% |
| Ergoteles LLC | 15,521 | $23,282 | 0.00% |
| UBS Group AG | 3,440 | $5,160 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 15,276 | $22,914 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,570 | $17,355 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 89,986 | $134,979 | 0.00% |